{"title":"印度结核病流行病学和结核病治疗中的耐药性","authors":"Patil Js","doi":"10.4172/2167-1052.1000E132","DOIUrl":null,"url":null,"abstract":"Tuberculosis (TB) is a ubiquitous, highly fatal contagious chronic granulomatous bacterial infection. It is mainly an infection of the lungs, but can affect almost any part of the body. Although TB is a preventable and treatable disease, yet it still poses a significant threat globally. Approximately, nine million new cases and one‐and‐a‐half million TB‐related deaths occur each year; the incidence may vary. In 2012, an estimated 8.6 million people developed TB and 1.3 million died from the disease.","PeriodicalId":7385,"journal":{"name":"Advances in Pharmacoepidemiology and Drug Safety","volume":"26 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Epidemiology of Tuberculosis and Drug Resistance in Tuberculosis Treatment in Indian Patients\",\"authors\":\"Patil Js\",\"doi\":\"10.4172/2167-1052.1000E132\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Tuberculosis (TB) is a ubiquitous, highly fatal contagious chronic granulomatous bacterial infection. It is mainly an infection of the lungs, but can affect almost any part of the body. Although TB is a preventable and treatable disease, yet it still poses a significant threat globally. Approximately, nine million new cases and one‐and‐a‐half million TB‐related deaths occur each year; the incidence may vary. In 2012, an estimated 8.6 million people developed TB and 1.3 million died from the disease.\",\"PeriodicalId\":7385,\"journal\":{\"name\":\"Advances in Pharmacoepidemiology and Drug Safety\",\"volume\":\"26 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Pharmacoepidemiology and Drug Safety\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2167-1052.1000E132\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Pharmacoepidemiology and Drug Safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-1052.1000E132","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Epidemiology of Tuberculosis and Drug Resistance in Tuberculosis Treatment in Indian Patients
Tuberculosis (TB) is a ubiquitous, highly fatal contagious chronic granulomatous bacterial infection. It is mainly an infection of the lungs, but can affect almost any part of the body. Although TB is a preventable and treatable disease, yet it still poses a significant threat globally. Approximately, nine million new cases and one‐and‐a‐half million TB‐related deaths occur each year; the incidence may vary. In 2012, an estimated 8.6 million people developed TB and 1.3 million died from the disease.